New antibody trial hopes to outsmart Cancer's defenses

NCT ID NCT05267626

Recruiting now Disease control Sponsor: Aulos Bioscience, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 22 times

Summary

This study tests a new drug called AU-007 in people with advanced solid tumors (like melanoma or lung cancer) that cannot be removed by surgery or have spread. The drug is designed to help the immune system fight cancer more effectively. About 159 participants will receive AU-007 alone or with other drugs to find the safest dose and see if it can shrink tumors. The goal is to control the disease, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Atlantic Healthcare System
RECRUITING

Morristown, New Jersey, 07960, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Austin Health
RECRUITING

Heidelberg, Victoria, 3084, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Carolina Biooncology Institute
RECRUITING

Huntersville, North Carolina, 28078, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030-4000, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Minnesota Oncology and Hematology PA
RECRUITING

Minneapolis, Minnesota, 55404-4526, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Monash Health
RECRUITING

Clayton, Victoria, 3168, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Peninsula & South Eastern Haematology and Oncology Group
RECRUITING

Frankston, Victoria, 3199, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
START Midwest
RECRUITING

Grand Rapids, Michigan, 49503-2563, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
START South Texas Accelerated Research Therapeutics
RECRUITING

San Antonio, Texas, 78229, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sarah Cannon Research Institute
RECRUITING

Nashville, Tennessee, 37203-1619, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Southern Oncology Clinical Research Unit
RECRUITING

Bedford Park, South Australia, 5042, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Southside Cancer Care Centre
RECRUITING

Miranda, New South Wales, 2228, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sunshine Hospital
RECRUITING

Saint Albans, Victoria, 3021, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sylvester Comprehensive Cancer Center - Miami
RECRUITING

Miami, Florida, 33136-1002, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Texas Oncology (Balcones) - SCRI
RECRUITING

Austin, Texas, 78731-4214, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
The Alfred Hospital
RECRUITING

Melbourne, Victoria, 3004, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of Utah - Huntsman Cancer Institute
RECRUITING

Salt Lake City, Utah, 84112, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Washington University
RECRUITING

St Louis, Missouri, 63110-1010, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMOR CUTANEOUS MELANOMA METASTATIC CANCER NON-SMALL CELL LUNG CANCER